With no weight-loss drug and a focus on cancer, the FTSE 100 giant needs to perfectly manage its patent cliff-edge ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback